CRINETICS PHARMACEUTICALS IN (CRNX) Institutional Ownership Changes & 13F Activity

CRINETICS PHARMACEUTICALS IN (CRNX). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q4 2025). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Fmr Llc, Wellington Management Group Llp, Driehaus Capital Management Llc, Price T Rowe Associates Inc, and Janus Henderson Group Plc.

InstitutionTypeChange in sharesChange Position %SharesReported stock balancePortfolio quarterFiling date
Cornerstone Financial Management LlcBuy+34—34$1.58KQ4 2025Aug 28, 2026
Advisors Asset Management, Inc.Sell-6,652-100.0%0$0.00Q4 2025Aug 26, 2026
Ensign Peak Advisors, IncSell-19,392-6.6%275,616$12.83MQ4 2025Aug 18, 2026
Bell Investment Advisors, IncBuy+17—17$792.00Q4 2025Feb 24, 2026
Raymond James Financial IncBuy+33,354—33,354$1.55MQ4 2025Feb 18, 2026
Mackenzie Financial CorpBuy+5,666—5,666$267.98KQ4 2025Feb 18, 2026
Fmr LlcBuy+14,293,775—14,293,775$665.38MQ4 2025Feb 17, 2026
Wellington Management Group LlpBuy+8,037,889—8,037,889$374.16MQ4 2025Feb 17, 2026
Driehaus Capital Management LlcBuy+6,387,740—6,387,740$297.35MQ4 2025Feb 17, 2026
Price T Rowe Associates IncBuy+5,224,387—5,224,387$243.20MQ4 2025Feb 17, 2026
Janus Henderson Group PlcBuy+4,440,691—4,440,691$206.60MQ4 2025Feb 17, 2026
Ecor1 Capital, LlcBuy+4,288,120—4,288,120$199.61MQ4 2025Feb 17, 2026
Point72 Asset Management, L.P.Buy+2,337,034—2,337,034$108.79MQ4 2025Feb 17, 2026
Paradigm Biocapital Advisors LpBuy+2,210,774—2,210,774$102.91MQ4 2025Feb 17, 2026
Baker Bros. Advisors LpBuy+1,648,869—1,648,869$76.75MQ4 2025Feb 17, 2026
Novo Holdings A/SBuy+1,625,000—1,625,000$75.64MQ4 2025Feb 17, 2026
Rtw Investments, LpBuy+1,351,326—1,351,326$62.90MQ4 2025Feb 17, 2026
First Light Asset Management, LlcBuy+1,194,263—1,194,263$55.59MQ4 2025Feb 17, 2026
Orbimed Advisors LlcBuy+999,000—999,000$46.50MQ4 2025Feb 17, 2026
Hood River Capital Management LlcBuy+897,403—897,403$41.77MQ4 2025Feb 17, 2026
Bank Of America CorpBuy+801,314—801,314$37.30MQ4 2025Feb 17, 2026
Northern Trust CorpBuy+769,823—769,823$35.84MQ4 2025Feb 17, 2026
Ameriprise Financial IncBuy+601,190—601,190$27.99MQ4 2025Feb 17, 2026
Adar1 Capital Management, LlcBuy+309,368—309,368$14.40MQ4 2025Feb 17, 2026
Millennium Management LlcBuy+300,335—300,335$13.98MQ4 2025Feb 17, 2026
Cormorant Asset Management, LpBuy+300,000—300,000$13.96MQ4 2025Feb 17, 2026
Citadel Advisors LlcBuy+254,720—254,720$11.86MQ4 2025Feb 17, 2026
Balyasny Asset Management L.P.Buy+233,197—233,197$10.86MQ4 2025Feb 17, 2026
Gordonmd Global Investments LpBuy+224,135—224,135$10.43MQ4 2025Feb 17, 2026
Rice Hall James & Associates, LlcBuy+171,830—171,830$8.00MQ4 2025Feb 17, 2026
Showing 30 of 230

Frequently asked questions about CRNX activity

  • Which institutional owners are buying CRNX?

    Institutional owners buying CRNX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in CRNX activity?

    "Buy" means an investor increased their reported position in CRNX compared to the prior reporting period. This reflects growing exposure to CRINETICS PHARMACEUTICALS IN (CRNX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in CRNX increasing?

    Institutional interest in CRNX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.